Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220021985 220005332 1.7 65.4 Curative (C) 2013-10-27 2014-01-06 AML17 TRIAL Y N 220020646 AML17 TRIAL
220021986 220005340 1.77 77.1 Adjuvant (A) 2014-03-08 2014-08-08 AML17 TRIAL 02 N 220020654 AML17 TRIAL
220021987 220005353 1.67 103 Curative (C) 2019-09-20 2019-09-24 FLAG + Idarubicin 02 N 220020673 FLAG + IDARUBICIN
220021988 220005360 1.98 66.6 Curative (C) 2015-07-21 2015-10-02 AML17 TRIAL Y N 220020676 AML17 TRIAL
220021989 220005390 1.53 109.9 Adjuvant (A) 2016-08-22 2017-09-26 FLAG + Idarubicin 01 N 220020746 FLAG + IDARUBICIN
220021991 220020683 1.85 67.5 Palliative (P) 2019-05-12 2019-08-14 Trial Unspecified Y null 220021137 TRIAL
220021992 220012909 1.85 77 Curative (C) 2019-01-08 2019-01-19 Trial Unspecified N N 220021161 TRIAL
220021993 220005534 1.54 84.7 Curative (C) 2014-09-02 2014-09-02 Trial Unspecified Y N 220021175 TRIAL
220021994 220005556 1.65 0 Curative (C) 1536-03-08 1536-03-08 Trial Unspecified Y N 220021255 TRIAL
220021995 220017130 1.68 109.6 Curative (C) 2018-08-30 2018-10-19 AML 19 TRIAL Y N 220021572 AML19 TRIAL
220021997 220005718 1.62 84.6 Disease modification (D) 2017-06-11 2017-11-16 AML 19 TRIAL 01 N 220021690 AML19 TRIAL
220021998 220005723 1.58 64.4 null 2018-12-14 2018-12-17 AML 19 TRIAL Y null 220021720 AML19 TRIAL
220021999 220005726 1.7 83.6 Curative (C) 2018-10-12 2019-01-12 AML 19 TRIAL Y N 220021721 AML19 TRIAL
220022000 220005761 1.78 54 Not known (9) 2017-07-21 2017-09-27 Trial Unspecified 01 N 220021789 TRIAL
220022002 220005809 1.61 84.7 Curative (C) 2019-10-10 2019-10-14 Trial Unspecified N N 220021942 TRIAL
220022003 220005821 1.83 90.4 Curative (C) 2014-05-11 2014-05-20 Trial Unspecified Y N 220021958 TRIAL
220022004 220013080 0 70.8 Disease modification (D) 2013-10-06 2014-05-29 Hydroxycarbamide 02 N 220021966 HYDROXYCARBAMIDE
220022005 220005879 1.48 null Palliative (P) 2014-01-30 2014-02-06 Cytarabine Low Dose N N 220022138 CYTARABINE
220022006 220005887 null 87.1 Disease modification (D) 2014-06-26 2014-09-18 Hydroxycarbamide null N 220022174 HYDROXYCARBAMIDE
220022007 220005902 1.83 65.3 Palliative (P) 2014-10-22 2014-10-22 Hydroxycarbamide N N 220022212 HYDROXYCARBAMIDE
220022008 220017210 null 82.6 Palliative (P) 2016-01-24 2016-06-06 Hydroxycarbamide 02 N 220022379 HYDROXYCARBAMIDE
220022009 220005970 null 58.3 Palliative (P) 2019-07-18 2019-07-18 Hydroxycarbamide 02 null 220022475 HYDROXYCARBAMIDE
220022010 220005975 null 77.9 Curative (C) 2018-04-11 2018-04-14 Hydroxycarbamide N null 220022478 HYDROXYCARBAMIDE
220022011 220017229 1.75 null Palliative (P) null 2014-09-12 Hydroxycarbamide Y N 220022679 HYDROXYCARBAMIDE
220022012 220006026 1.66 68 Curative (C) 2014-09-25 2014-09-25 Cytarabine low (10to20mg/m2) IV/SC 2 N 220022722 CYTARABINE
220022013 220006047 1.74 92.9 null 2014-03-18 2014-04-27 CYTARABINE N N 220022807 CYTARABINE
220022014 220006063 null 43 Disease modification (D) 2019-04-03 2019-04-07 AML Interim Guidelines FLA -Ida N N 220022911 NOT MATCHED
220022015 220006071 1.71 54 Curative (C) 2015-07-08 2015-10-07 AML Interim Guidelines FLA -Ida N N 220022988 NOT MATCHED
220022017 220006091 1.63 30.4 Disease modification (D) null 2014-12-16 AML MyeChild 01 FLA null null 220023007 NOT MATCHED
220022018 220006101 null 52 Curative (C) 2018-08-07 2018-08-08 AML Relapsed FLA - DaunoXome null null 220023070 NOT MATCHED
220022019 220006160 0 81.6 Disease modification (D) 2014-03-13 2014-03-15 Cytarabine Low Dose N N 220023340 CYTARABINE
220022020 220006164 1.76 65.4 Palliative (P) 2018-10-29 2018-11-01 null N N 220023346 NOT MATCHED
220022021 220006182 1.62 64.4 Disease modification (D) 2018-05-21 2018-05-22 Hydroxycarbamide 02 N 220023471 HYDROXYCARBAMIDE
220022022 220006184 null 70 Curative (C) 2016-11-18 2017-01-20 Cytarabine Low Dose N null 220023478 CYTARABINE
220022023 220006190 null 88.3 Curative (C) null 2019-03-14 Cytarabine Low Dose N null 220023489 CYTARABINE
220022024 220006231 1.8 71.8 Palliative (P) 2014-01-16 2014-07-03 Cytarabine + Etoposide + Tretinoin 02 N 220023646 NOT MATCHED
220022025 220006250 1.74 18 Curative (C) 2018-11-06 2019-03-14 APML SR Ind ATO + ATRA Y N 220023701 NOT MATCHED
220022026 220006258 null null null 2016-09-16 2017-09-14 Hydroxycarbamide Y N 220023737 HYDROXYCARBAMIDE
220022027 220013372 1.78 null Palliative (P) 2018-11-10 2018-11-10 Hydroxycarbamide null null 220023759 HYDROXYCARBAMIDE
220022028 220013379 -1 69 Curative (C) null 2013-10-27 AML MyeChild 01 A Mitozantrone/Cytarabine N N 220023793 NOT MATCHED
220022029 220006278 1.74 64.6 Disease modification (D) 2015-09-11 2015-09-11 Hydroxycarbamide null null 220023811 HYDROXYCARBAMIDE
220022030 220013388 1.08 78 Curative (C) 2017-07-20 2018-03-15 CYTARABINE 2 N 220023821 CYTARABINE
220022031 220006297 null null Disease modification (D) null 2019-05-20 AML MyeChild 01 FLA 02 N 220023866 NOT MATCHED
220022032 220006341 null 99 Curative (C) 2017-07-26 2017-08-10 null null null 220024098 NOT MATCHED
220022033 220006399 null null Disease modification (D) 2016-07-23 2016-07-23 Rituximab N N 220024326 RITUXIMAB
220022034 220006409 0 65.2 Curative (C) 2015-11-23 2015-11-23 Alemtuz+Fludara+Melphalan RIC MUD null null 220024353 ALEMTUZUMAB + FLUDARABINE + MELPHALAN
220022035 220006456 null 78 Disease modification (D) 2018-09-30 2018-10-03 AML 18 Pilot Trial N N 220024528 PILOT TRIAL
220022036 220022253 null 63.5 Curative (C) 2019-04-05 2019-07-16 AML18 PILOT TRIAL N N 220024708 PILOT TRIAL
220022037 220021452 0 127.3 Curative (C) 2015-01-29 2015-01-29 Rituximab 2 N 220024810 RITUXIMAB
220022038 220022340 1.78 101.5 Curative (C) 2016-03-29 2016-03-29 ALEMTUZUMAB + FLUDARABINE + MELPHALAN 2 N 220024847 ALEMTUZUMAB + FLUDARABINE + MELPHALAN